PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy

OBJECTIVES: To investigate the expression of programmed death-ligand 1 (PD-L1) in breast cancer in association with incomplete pathological response (PR) to neoadjuvant chemotherapy (NAC). METHODS: PD-L1 expression was evaluated using immunohistochemistry in post-operative, post-NAC samples of 60 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhesa, Ahmad, Awad, Heyam, Bloukh, Sarah, Al-Balas, Mahmoud, El-Sadoni, Mohammed, Qattan, Duaa, Azab, Bilal, Saleh, Tareq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891930/
https://www.ncbi.nlm.nih.gov/pubmed/35225058
http://dx.doi.org/10.1177/03946320221078433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891930/
https://www.ncbi.nlm.nih.gov/pubmed/35225058
http://dx.doi.org/10.1177/03946320221078433

Ejemplares similares